Biology of Bone Cancer Pain
Open Access
- 15 October 2006
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (20), 6231s-6235s
- https://doi.org/10.1158/1078-0432.ccr-06-0682
Abstract
Bone cancer pain is a devastating manifestation of metastatic cancer. Unfortunately, current therapies can be ineffective, and when they are effective, the duration of the patient's survival typically exceeds the duration of pain relief. New, mechanistically based therapies are desperately needed. Study of experimental animal models has provided insight into the mechanisms that drive bone cancer pain and provides an opportunity for developing targeted therapies. Mechanisms that drive bone cancer pain include tumor-directed osteoclast-mediated osteolysis, tumor cells themselves, tumor-induced nerve injury, stimulation of transient receptor potential vanilloid type 1 ion channel, endothelin A, and host cell production of nerve growth factor. Current and future therapies include external beam radiation, osteoclast-targeted inhibiting agents, anti-inflammatory drugs, transient receptor potential vanilloid type 1 antagonists, and antibody therapies that target nerve growth factor or tumor angiogenesis. It is likely that a combination of these therapies will be superior to any one therapy alone.Keywords
This publication has 41 references indexed in Scilit:
- Advances in understanding bone cancer painJournal of Cellular Biochemistry, 2005
- Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitizationPain, 2005
- Radiation‐Induced Alteration of Pain‐Related Signals in an Animal Model with Bone Invasion from CancerAnnals of the New York Academy of Sciences, 2004
- Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosisPain, 2004
- Analgesic effects of a soy-containing diet in three murine bone cancer pain modelsThe Journal of Pain, 2004
- The treatment of cancer painDrugs of Today, 2004
- Receptor Endocytosis and Dendrite Reshaping in Spinal Neurons After Somatosensory StimulationScience, 1995
- Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of lifeJournal of Pain and Symptom Management, 1990
- Pain relief in active patients with cancer: analgesic drugs are the foundation of management.BMJ, 1989
- Substance P- and CGRP-immunoreactive nerves in bonePeptides, 1988